<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nogr-596</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTION</subject></subj-group></article-categories><title-group><article-title>ХРОНИЧЕСКОЕ ВОСПАЛЕНИЕ ОРГАНОВ ЖЕЛУДОЧНО-КИШЕЧНОГО ТРАКТА И КАНЦЕРОГЕНЕЗ. БИОЛОГИЧЕСКИЕ АСПЕКТЫ ВЗАИМОСВЯЗИ</article-title><trans-title-group xml:lang="en"><trans-title>CHRONIC INFLAMMATION OF THE GASTROINTESTINAL TRACT AND CARCINOGENESIS. BIOLOGICAL ASPECTS OF THE RELATIONSHIP</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сарибекян</surname><given-names>Э. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Saribekyan</surname><given-names>E. K.</given-names></name></name-alternatives><email xlink:type="simple">mammolog3@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубовская</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubovskaia</surname><given-names>A. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шкурников</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shkurnikov</surname><given-names>M. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский научно-исследовательский онкологический институт им. П. А. Герцена - филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» Минздрава России (МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow research cancer Institute. P. A. Herzen-branch of the national medical research radiological center of the Ministry of health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Московский научно-исследовательский онкологический институт им. П. А. Герцена - филиал ФГБУ «Национальный медицинский исследовательский радиологический центр» Минздрава России (МНИОИ им. П. А. Герцена-филиал ФГБУ «НМИРЦ» Минздрава России)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow research cancer Institute. P. A. Herzen-branch of the national medical research radiological center of the Ministry of health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>76</fpage><lpage>82</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сарибекян Э.К., Зубовская А.Г., Шкурников М.Ю., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Сарибекян Э.К., Зубовская А.Г., Шкурников М.Ю.</copyright-holder><copyright-holder xml:lang="en">Saribekyan E.K., Zubovskaia A.G., Shkurnikov M.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/596">https://www.nogr.org/jour/article/view/596</self-uri><abstract><p>В современной медицинской литературе достаточно широко представлены материалы, иллюстрирующие связь хронического воспаления с развитием злокачественных опухолей. Воспалительный компонент играет значительную роль как на стадии предопухолевых изменений (гиперплазия, атрофия, дистрофия и др.), так и на стадии формирования злокачественной опухоли, ее инвазии в окружающие ткани, прогрессирования и метастазирования. Доказано, что хроническое воспаление оказывает также непосредственное воздействие на компоненты иммунной защиты, нарушение которой способствует прогрессированию опухолевого процесса. Кроме вышеуказанных процессов, воспаление оказывает воздействие на изменения генов и генома, способствуя накоплению проканцерогенных мутаций, созданию благоприятствующей канцерогенезу микросреды и повышая резистентность к противоопухолевому лечению. Синергичное действие вышеуказанных факторов приводит к образованию опухолей различных локализаций. Цель - проанализировать значение отдельных факторов, участвующих одновременно в процессах хронического воспаления и канцерогенеза и оценить взаимосвязь между этими факторами при развитии опухолей различных локализаций. Наибольшее значение имеет понимание данных процессов в гастроэнтерологии, в связи с распространенностью хронических воспалительных процессов ЖКТ (язвенной болезни, неспецифического язвенного колита, болезни Крона). Понимание молекулярно-клеточных механизмов воспаления может служить основой для дальнейших исследований в области диагностики, терапии и профилактики злокачественных новообразований органов желудочно-кишечного тракта.</p></abstract><trans-abstract xml:lang="en"><p>The interplay between chronic inflammation and tumorigenesis has been widely discussed. Chronic inflammation induces premalignant changes in tissues (tissue metaplasia, atrophic changes, etc.) and promotes local tumor invasion, metastatic spread and tumor progression. Chronic inflammation can also induce changes of the DNA, promoting accumulation of pro-oncogenic mutations, which results in development of specific tumor environment as well as selection of chemo- and radioresistant tumor cells. Suppression of innate and acquired immunity caused by chronic inflammation also promotes tissue changes, increasing the likelihood of tumor development. The synergistic action of all above mentioned factors is implicated in development of multiple malignant neoplasms in a variety of organs. In this article the intricate interplay between chronic inflammation and tumorigenesis in various organs and organ systems is discussed. The understanding of these processes is of greatest importance, especially in gastroenterology, caused by relative prevalence of inflammatory bowel diseases and peptic ulcer disease. Further understanding of these processes can help further improve the diagnostic and treatment approaches to malignant tumors, as well as prevention of inflammation-induced tumor progression.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническое воспаление</kwd><kwd>канцерогенез</kwd><kwd>проонкогенные мутации</kwd><kwd>микросателлитная нестабильность</kwd><kwd>нуклеарный фактор NF-κB</kwd><kwd>фактор некроза опухоли</kwd><kwd>микроРНК</kwd></kwd-group><kwd-group xml:lang="en"><kwd>miR-155</kwd><kwd>Helicobacter pylori</kwd><kwd>chronic inflammation</kwd><kwd>tumorigenesis</kwd><kwd>pro-oncogenic mutations</kwd><kwd>microsatellite instability</kwd><kwd>Nuclear factor of kappa light gene polypeptide gene enhancer in B cells (NF-κB)</kwd><kwd>MicroRNAs</kwd><kwd>tumor necrosis factor</kwd><kwd>miR-155</kwd><kwd>Helicobacter pylori</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dawit K., Wook J. C., Jennifer C., Kristin A., Eckert P. М., Glazer A. L., Bothwell M., and Sweasy J. B. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014 Mar-Apr; 49(2): 116-139.</mixed-citation><mixed-citation xml:lang="en">Dawit K., Wook J. C., Jennifer C., Kristin A., Eckert P. М., Glazer A. L., Bothwell M., and Sweasy J. B. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014 Mar-Apr; 49(2): 116-139.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Coussens L. M., Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26; 420(6917):860-7.</mixed-citation><mixed-citation xml:lang="en">Coussens L. M., Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26; 420(6917):860-7.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, Volume 30, Issue 7, 1 July 2009, Pages 1073-1081, https://doi.org/10.1093/carcin/bgp127.</mixed-citation><mixed-citation xml:lang="en">Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, Volume 30, Issue 7, 1 July 2009, Pages 1073-1081, https://doi.org/10.1093/carcin/bgp127.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dizdaroglu M. Oxidatively induced DNA damage: mechanisms, repair and disease.Cancer Lett. 2012 Dec 31; 327(1-2):26-47. Epub 2012 Jan 28.</mixed-citation><mixed-citation xml:lang="en">Dizdaroglu M. Oxidatively induced DNA damage: mechanisms, repair and disease.Cancer Lett. 2012 Dec 31; 327(1-2):26-47. Epub 2012 Jan 28.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H. W., Murakami A., Williams M. V., Ohigashi H. Mutagenicity of reactive oxygen and nitrogen species as detected by co-culture of activated inflammatory leukocytes and AS52 cells. Carcinogenesis. 2003 Feb; 24(2):235-41.</mixed-citation><mixed-citation xml:lang="en">Kim H. W., Murakami A., Williams M. V., Ohigashi H. Mutagenicity of reactive oxygen and nitrogen species as detected by co-culture of activated inflammatory leukocytes and AS52 cells. Carcinogenesis. 2003 Feb; 24(2):235-41.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McCool K.W., Miyamoto S. Review DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol Rev. 2012 Mar; 246(1):311-26.</mixed-citation><mixed-citation xml:lang="en">McCool K.W., Miyamoto S. Review DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol Rev. 2012 Mar; 246(1):311-26.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Karl S., Pritschow Y., Volcic M., Häcker S., Baumann B., Wiesmüller L., Debatin K. M., Fulda S. Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response. J Cell Mol Med. 2009 Oct; 13(10):4239-56.</mixed-citation><mixed-citation xml:lang="en">Karl S., Pritschow Y., Volcic M., Häcker S., Baumann B., Wiesmüller L., Debatin K. M., Fulda S. Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response. J Cell Mol Med. 2009 Oct; 13(10):4239-56.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Greten F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 2004, vol. 118 (pg. 285-296).</mixed-citation><mixed-citation xml:lang="en">Greten F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 2004, vol. 118 (pg. 285-296).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Volcic M., Karl S., Baumann B., Salles D., Daniel P., Fulda S., Wiesmüller L. NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexesNucleic Acids Res. 2012 Jan; 40(1):181-95.</mixed-citation><mixed-citation xml:lang="en">Volcic M., Karl S., Baumann B., Salles D., Daniel P., Fulda S., Wiesmüller L. NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexesNucleic Acids Res. 2012 Jan; 40(1):181-95.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Balkwill F. Tumour necrosis factor and cancer, Nat. Rev. Cancer, 2009, vol. 9 (pg. 361-371)</mixed-citation><mixed-citation xml:lang="en">Balkwill F. Tumour necrosis factor and cancer, Nat. Rev. Cancer, 2009, vol. 9 (pg. 361-371)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison M.L. et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose, J. Clin. Oncol., 2007, vol. 25 (pg. 4542-4549).</mixed-citation><mixed-citation xml:lang="en">Harrison M.L. et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose, J. Clin. Oncol., 2007, vol. 25 (pg. 4542-4549).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani A. et al. Cancer-related inflammation, Nature, 2008, vol. 454 (pg. 436-444).</mixed-citation><mixed-citation xml:lang="en">Mantovani A. et al. Cancer-related inflammation, Nature, 2008, vol. 454 (pg. 436-444).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sakurai T. et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, Cancer Cell, 2008, vol. 14 (pg. 156-165).</mixed-citation><mixed-citation xml:lang="en">Sakurai T. et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, Cancer Cell, 2008, vol. 14 (pg. 156-165).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Babar I. A., Czochor J., Steinmetz A., Weidhaas J. B., Glazer P. M., Slack F. J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther. 2011 Nov 15; 12(10):908-14.</mixed-citation><mixed-citation xml:lang="en">Babar I. A., Czochor J., Steinmetz A., Weidhaas J. B., Glazer P. M., Slack F. J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther. 2011 Nov 15; 12(10):908-14.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Valeri N., Gasparini P., Fabbri M., Braconi C., Veronese A., Lovat F., Adair B., Vannini I., Fanini F., Bottoni A., Costinean S., Sandhu S. K., Nuovo G. J., Alder H., Gafa R., Calore F., Ferracin M., Lanza G., Volinia S., Negrini M., McIlhatton M.A., Amadori D., Fishel R., Croce C. M. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010 Apr 13; 107(15):6982-7.</mixed-citation><mixed-citation xml:lang="en">Valeri N., Gasparini P., Fabbri M., Braconi C., Veronese A., Lovat F., Adair B., Vannini I., Fanini F., Bottoni A., Costinean S., Sandhu S. K., Nuovo G. J., Alder H., Gafa R., Calore F., Ferracin M., Lanza G., Volinia S., Negrini M., McIlhatton M.A., Amadori D., Fishel R., Croce C. M. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010 Apr 13; 107(15):6982-7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Krichevsky A. M., Gabriely G. J. MiR-21: a small multi-faceted RNA. Cell Mol Med. 2009 Jan; 13(1):39-53.</mixed-citation><mixed-citation xml:lang="en">Krichevsky A. M., Gabriely G. J. MiR-21: a small multi-faceted RNA. Cell Mol Med. 2009 Jan; 13(1):39-53.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrie C. H., Soneji S., Marafioti T., Cooper C. D., Palazzo S., Paterson J. C., Cattan H., Enver T., Mager R., Boultwood J., Wainscoat J. S., Hatton C. S. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007 Sep 1; 121(5):1156-61.</mixed-citation><mixed-citation xml:lang="en">Lawrie C. H., Soneji S., Marafioti T., Cooper C. D., Palazzo S., Paterson J. C., Cattan H., Enver T., Mager R., Boultwood J., Wainscoat J. S., Hatton C. S. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007 Sep 1; 121(5):1156-61.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Loeb L. A. et al. DNA polymerases and human disease. Nat. Rev. Genet., 2008, vol. 9 (pg. 594-604).</mixed-citation><mixed-citation xml:lang="en">Loeb L. A. et al. DNA polymerases and human disease. Nat. Rev. Genet., 2008, vol. 9 (pg. 594-604).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mirzaee V. et al. Helicobacter pylori infection and expression of DNA mismatch repair proteins. World J. Gastroenterol., 2008, vol. 14 (pg. 6717-6721).</mixed-citation><mixed-citation xml:lang="en">Mirzaee V. et al. Helicobacter pylori infection and expression of DNA mismatch repair proteins. World J. Gastroenterol., 2008, vol. 14 (pg. 6717-6721).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Brentnall T. A. et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 1996, vol. 56 (pg. 1237-1240).</mixed-citation><mixed-citation xml:lang="en">Brentnall T. A. et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 1996, vol. 56 (pg. 1237-1240).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kawashima T., Kosaka A., Yan H., Guo Z., Uchiyama R., Fukui R., Kaneko D., Kumagai Y., You D. J., Carreras J., Uematsu S., Jang M. H., Takeuchi O., Kaisho T., Akira S., Miyake K., Tsutsui H., Saito T., Nishimura I., Tsuji N. M. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity. 2013 Jun 27; 38(6):1187-97.</mixed-citation><mixed-citation xml:lang="en">Kawashima T., Kosaka A., Yan H., Guo Z., Uchiyama R., Fukui R., Kaneko D., Kumagai Y., You D. J., Carreras J., Uematsu S., Jang M. H., Takeuchi O., Kaisho T., Akira S., Miyake K., Tsutsui H., Saito T., Nishimura I., Tsuji N. M. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β. Immunity. 2013 Jun 27; 38(6):1187-97.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
